Reference - Detail
|Author||Kokuryo T, Senga T, Yokoyama Y, Nagino M, Nimura Y, Hamaguchi M.|
|Title||Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma.|
We investigated the role of Nek2, a member of the serine/threonine kinase family, Nek, in the tumorigenic growth of cholangiocarcinoma cells. Expression of Nek2 is elevated in cholangiocarcinoma in a tumor-specific manner as compared with that of normal fibroblast cells. Expression of exogenous Nek2 did not perturb the growth of cholangiocarcinoma cells, whereas suppression of the Nek2 expression with siRNA resulted in the inhibition of cell proliferation and induced cell death. In xenograft-nude mouse model, s.c. injection of Nek2 siRNA around the tumor nodules resulted in reduction of tumor size as compared with those of control siRNA injection. In peritoneal dissemination model, Nek2 siRNA-treated mice showed statistically longer survival periods in comparison with those of the control siRNA-treated mice. Taken together, our data indicate a pivotal role of Nek2 in tumorigenic growth of cholangiocarcinoma.
|MeSH||Animals Bile Duct Neoplasms / enzymology* Bile Duct Neoplasms / genetics Bile Duct Neoplasms / pathology Bile Ducts, Intrahepatic / enzymology* Bile Ducts, Intrahepatic / pathology Cell Death / physiology Cell Growth Processes / physiology Cell Line, Tumor Cholangiocarcinoma / enzymology* Cholangiocarcinoma / genetics Cholangiocarcinoma / pathology DNA, Complementary / biosynthesis DNA, Complementary / genetics Gene Expression Humans Liver / enzymology Male Mice Mice, Nude NIMA-Related Kinases Peritoneal Neoplasms / enzymology* Peritoneal Neoplasms / genetics Peritoneal Neoplasms / secondary* Protein-Serine-Threonine Kinases / antagonists & inhibitors* Protein-Serine-Threonine Kinases / biosynthesis Protein-Serine-Threonine Kinases / genetics RNA, Small Interfering / genetics|
|Human and Animal Cells|